2024 SPEAKERS

Anthony Keefe

Senior Vice President - Innovation

X-Chem Pharmaceuticals

TPD Expert Speaker – Chris Tame, Celeris Therapeutics

Chris Tame

Head of drug discovery

Celeris Therapeutics

David Shorthouse

Lecturer

University College London, School of Pharmacy

Diogo Feleciano

Co-Founder & Chief Operating Officer

Booster Therapeutics

Edward Tate

Professor & Chair of Chemical Biology

Imperial College London

Enrica Colasurdo

Principal Scientist

Sibylla Biotech

Frank Dekker

Associate Professor

University of Groningen

TPD Expert Speaker – Graham Simpson, Dunad Therapeutics

Graham Simpson

Senior Vice President - Drug Discovery

Dunad Therapeutics

György Miklós Keserű

Principal Investigator

Drug Innovation Centre, Research Centre for Natural Sciences, Hungary

TPD Expert Speaker – Henrik Daub, NEOsphere Biotechnologies

Henrik Daub

Chief Scientific officer

NEOsphere Biotechnologies

Ivan Dikic

Professor & Steering Board Member

PROXIDRUGS

John Caldwell

Senior Staff Scientist

The Institute of Cancer Research

Kaat Durinck

Professor

Ghent University

Katie Spooner

Research Analyst

Beacon

TPD Expert Speaker – Kirsten McAulay, Centre for Target Protein Degradation, University of Dundee

Kirsten McAulay

Team Leader

Centre for Target Protein Degradation, University of Dundee

Kristin Riching

Senior Research Scientist, Research & Development

Promega

Laura Gasparini

Tau Pathobiology & Area Leader

AbbVie

Marcus Hartmann

Group Leader and Chair of Structural Biology

Max Planck Institute for Biology Tübingen & University of Tübingen

TPD Expert Speaker – Marga Puente, GlaxoSmithKline

Margarita Puente Felipe

Scientific Team Leader

GlaxoSmithKline

Markus Queisser

Director - Scientific Leader

GlaxoSmithKline

TPD Expert Speaker – Markus Schade, AstraZeneca

Markus Schade

Senior Scientist - NMR Fragment Screening

AstraZeneca

TPD Expert Speaker – Martin Schwalm, Goethe University Frankfurt

Martin Schwalm

Structural Genomics Consortium Scientist

Goethe University Frankfurt

Matthew Wakeham

Team Leader

BASF

TPD Expert Speaker – Oliver Hsia, University of Dundee, Centre for Targeted Protein Degradation

Oliver Hsia

Postdoctoral Research Scientist

University of Dundee, Centre for Targeted Protein Degradation

Paula O’Connor

Senior Vice President - Clinical Development

Nurix Therapeutics

Pearl Huang

CEO

Dunad Therapeutics

Ralph Tiedt

VP Biology

Monte Rosa Therapeutics

Rhiannon David

Director - Microphysiological Systems

AstraZeneca

Richard Boyce

Senior Director - Research & Chemistry

PhoreMost

Shawn Schiller

Director

Foghorn Therapeutics

TPD Expert Speaker – Shyra Gardai, EpiBiologics

Shyra Gardai

Chief Scientific Officer

EpiBiologics

TPD Expert Speaker – Simon Glerup, Draupnir Bio

Simon Glerup

Chief Scientific Officer

Draupnir Bio Aps

TPD Expert Speaker – Stefan Knapp, SGC Frankfurt

Stefan Knapp

Principal Investigator

SGC Frankfurt

TPD Expert Speaker – Swen Hoelder, The Institute of Cancer Research

Swen Hoelder

Professor & Interim Director

The Institute of Cancer Research

TPD Expert Speaker – Tauseef Butt, Progenra

Tauseef Butt

President and CEO

Progenra

TPD Expert Speaker – Victor Guallar, Barcelona Supercomputing Center

Victor Guallar

Group Manager - Electronic & Atomic Protein Modelling

Barcelona Supercomputing Center

Zacharias Thiel

Postdoctoral Fellow

Novartis Institutes for BioMedical Research (NIBR)

REGISTER INTEREST
PARTNER